688310.SH
迈得医疗
SSE · Healthcare · Medical - Instruments & Supplies · CN
CNY 15.05
−4.14%Year over year
Reported trailing growth
- Revenue
- +85.7%
- EBITDA
- —
- EBIT
- +195.2%
- EPS
- +238.7%
- Free cash flow
- +198.9%
- Operating cash flow
- +24.1%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.3%
- EBITDA
- -0.9%
- EBIT
- -11.9%
- Net income
- -1.0%
- EPS
- -11.1%
- Free cash flow
- +58.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026